NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/13/2024
Back to search
Official data from USPTO
NOBELPHARMA CONNECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOBELPHARMA CONNECT
ST13
US500000097655050Class
35, 36
Filing
97655050
Registration
7302991
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
02/13/2024
Trademark type
Word
Nice classes
35, 36
Filing date
10/31/2022
Registration date
02/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
02/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/31/2022
First use in commerce
08/31/2022
Drawing code
4
Owner type
99
Owner location
Tokyo, JP
Examiner
BERNS, LEE ANNE
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nobelpharma Co., Ltd.
Representatives
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business administration of patient reimbursement programs; business administration of pharmacy reimbursement programs and services; prior authorization facilitationalso known as healthcare cost containment servicesproviding expedited reviewprocessing and follow-up of prior authorization requests initiated by physicians' offices and pharmacies; pharmacy referral services provided via a global computer network
Class 36
Providing insurance and insurance reimbursement information; financial administration of patient reimbursement programscopay financial assistance programs; financial administration of pharmacy reimbursement programs and services; providing patient support servicesproviding insurance information to help patients understand their insurance and plan benefitsproviding information on insurance authorization formsappeals and statusproviding information on insurance-approved site-of-care facilitiesproviding insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims; patient support programproviding information about eligibility for financial assistance provided through patient benefits programs; providing consulting in the field of healthcare insurance benefits; healthcare insurance servicesbenefit verification services
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2023
PUBO
PUBLISHED FOR OPPOSITION
11/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/31/2023
GNRT
NON-FINAL ACTION E-MAILED
08/31/2023
CNRT
NON-FINAL ACTION WRITTEN
08/31/2023
DOCK
ASSIGNED TO EXAMINER
08/15/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/23/2023
ALIE
ASSIGNED TO LIE
01/21/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/16/2022
NWAP
NEW APPLICATION ENTERED
11/03/2022
Continuous trademark protection
Get notified about every new filing that threatens NOBELPHARMA CONNECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.